Search images on Google Product Monograph
Active Ingredients:
- evolocumab, 140 MG/ML
DIN: 02446057
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: 1 ML SINGLE USE PREFILLED SYRINGE AND AUTOINJECTOR
Schedule: Prescription
Company: AMGEN CANADA INC
ATC:
- C10 - LIPID MODIFYING AGENTS (ATC, WHO, Wiki)
- C10A - LIPID MODIFYING AGENTS, PLAIN (ATC, WHO)
- C10AX - Other lipid modifying agents (ATC, WHO)
- C10AX13 - EVOLOCUMAB (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 1ML